Purpose: 3D printed patient specific vascular models provide the ability to perform precise and repeatable benchtop experiments with simulated physiological blood flow conditions. This approach can be applied to CT-derived patient geometries to determine coronary flow related parameters such as Fractional Flow Reserve (FFR). To demonstrate the utility of this approach we compared bench-top results with non-invasive CT-derived FFR software based on a computational fluid dynamics algorithm and catheter based FFR measurements. Materials and Methods: Twelve patients for whom catheter angiography was clinically indicated signed written informed consent to CT Angiography (CTA) before their standard care that included coronary angiography (ICA) and conventional FFR (Angio-FFR). The research CTA was used first to determine CT-derived FFR (Vital Images) and second to generate patient specific 3D printed models of the aortic root and three main coronary arteries that were connected to a programmable pulsatile pump. Benchtop FFR was derived from pressures measured proximal and distal to coronary stenosis using pressure transducers. Results: All 12 patients completed the clinical study without any complication, and the three FFR techniques (Angio-FFR, CT-FFR, and Benchtop FFR) are reported for one or two main coronary arteries. The Pearson correlation among Benchtop FFR/ Angio-FFR, CT-FFR/ Benchtop FFR, and CT-FFR/ Angio-FFR are 0.871, 0.877, and 0.927 respectively. Conclusions: 3D printed patient specific cardiovascular models successfully simulated hyperemic blood flow conditions, matching invasive Angio-FFR measurements. This benchtop flow system could be used to validate CTderived FFR diagnostic software, alleviating both cost and risk during invasive procedures.
One such method is CT-derived FFR (CT-FFR). This non-invasive diagnostic method utilizes CT coronary geometry and computational fluid dynamics to estimate FFR. By being able to accurately and non-invasively diagnose CAD using these methods, the associated risks and costs with the invasive FFR procedures can be reduced. However, currently CT-FFR software can only be optimized with the use of theoretical models driven by large-scale clinical trials.
3D printing offers the ability to reduce the need for large-scale clinical trials by providing the ability to accurately replicate patient-specific anatomy and physiology in a tangible way with precise functional performance. Geometry extension and inclusion of pathologies such as atherosclerotic plaques or surrounding anatomical structures gives rise to 3D printed models in which flow measurements can be accurately tested 4 . This study leverages 3D printing to build patient specific phantoms that closely mimic the arterial wall mechanics as a validation tool for a diagnostic software.
We 3D printed patient specific coronary phantoms for 12 patients who underwent 320-detector coronary CTA (Aquilion ONE, Canon Medical Systems). Subjects were scanned using a CT-FFR protocol and FFR was measured via pressure wire in the catheterization lab as part of the subjects' normal clinical workflow. This project uses a CT-FFR research software (Canon Medical Systems) available on a Vitrea workstation (Vital images). The algorithm is based on a computational fluid dynamics algorithm and is designed to detect the ratio of pressures distal and proximal to an occlusion. This ratio is estimated under conditions which the ratio of the pressures is proportional to the ratio of the flows and can thus be used analogous to interventional FFR to estimate the hemodynamic significance of coronary lesions. 5 For each patient we 3D printed a phantom [2] [3] [4] [5] [6] [7] [8] [9] which was used in a benchtop simulation where flow conditions were measured with high accuracy using flow and pressure sensors. 4 This is one of the first studies where patient specific coronary models are being used to validate a CT-FFR. In this paper, we present the results and the comparison between the CT-FFR software, the Benchtop FFR, and the Angio-FFR to validate the CT-FFR software. Therefore; we have created a new approach to determine FFR through use of 3D printing with the ability to simulate hyperemic blood flow conditions matching invasive Angio-FFR measurements.
Materials and Methods

Study Design and Patient Inclusion Criteria:
Collection and analyses of all scan and patient data has been performed within the scope of a research protocol approved by the University at Buffalo Institutional Review Board (IRB). The study has been registered as a clinical trial under the same protocol approved by the university. (https://clinicaltrials.gov/show/NCT03149042) Patients who were scheduled for clinically indicated elective invasive coronary angiography (ICA) at Buffalo General Hospital were consented to participate in the clinical trial. The study inclusion criteria were patients with coronary artery disease scheduled for catheterization to characterize the disease severity. The exclusion criteria were as follows: less than 30 years of age, atrial fibrillation, renal insufficiency (estimated glomerulus filtration rate <60 mL/min/1.73m 2 ), active bronchospasm prohibiting the use of beta blockers, body mass index >40kg/m 2 , contraindication to iodinated contrast, patients not showing coronary calcification during calcium scoring procedures, and pregnancy.
The study schema is outlined in Figure 1 . The University at Buffalo cardiologists associated with the clinical trial verified the list of patients a week prior to the scheduled catheter interventions. They notified the engineers whenever a patient qualified for the study. On the day of the ICA procedure, informed consent was obtained from the patient to participate in the trial. Immediately before the planned ICA procedure, enrolled patients underwent a research CCTA scan on a 320x0.5 mm detector-row CT (Aquilion ONE, Canon Medical Systems, Japan). The phase window width for acquisition was 70-99% of the R-R cardiac wave cycle. 
CT-FFR Software:
Reconstructed CCTA images were imported into Vitrea segmentation software with specific cardiac functionality. Within Vitrea, a CT-FFR diagnostic algorithm software provided output CT-derived FFR estimates, also allowing for anatomical visualization as a multi-planar reformation, vessel centerlines and contours. (Figure 2 ) The algorithm takes four volumes from the CCTA scan between 70-99% of the cardiac R-R cycle and determines the FFR based on a computational fluid dynamics algorithm detecting hemodynamically significant coronary lesions. The user selects the phase with the least motion artifact and proceeds to the segmentation phase. He/she must verify that the software has selected the correct three main arteries. If needed, the contours and centerlines are manually edited. An FFR value is outputted for each of the three main coronary arteries (LAD, LCX, RCA) at a distal location that can be moved to a desired location. For this study the location of measurement was based on the lesion length to match that of the interventional FFR location.
ICA Procedure:
Each patient then underwent ICA where a catheter is threaded under x-ray imaging from typically the femoral artery or occasionally the brachiocephalic artery, through the aorta and then to the diseased region of the coronary vessel. A pressure catheter is inserted into the diseased vasculature and navigated to the desired location. Contrast is injected into the vessels after the pressure catheter insertion. The physicians recorded FFR, referred to as 'Angio-FFR' in this study, in the coronary vessels where it deems appropriate, and only those which were of clinical interest -one or two vessels per patient typically ( Figure 3 ). The FFR value was measured at two lesion lengths below the distal throat of the lesion. For the purpose of this clinical trial and reflecting clinical practice, only lesion in the three main coronary arteries were included. 
Figure 2. 3D reconstructed data volumes uploaded to Vital Images. (a) Automatic segmentation of main coronary arteries (LAD, LCX, RCA) with the LAD highlighted in red. (b) Visualization in a multi-planar view (c) in order to draw centerlines and contours (d) The FFR was calculated via Vitrea algorithm for each of the three main coronary arteries.
Benchtop Cardiovascular Model Design:
Using the Vitrea workstation, the aortic root and three main coronary arteries were segmented for each patient. The centerlines of each of the three main coronary arteries were edited as necessary to improve segmentation. The segmentation included the aortic root and coronary lumens for the 3 main coronary arteries. All heart tissue and calcium was excluded. A stereolithographic (STL) file of the segmentation containing only the aortic root and the three main coronary arteries was then created and exported by the software.
The STL file was then imported into Autodesk Meshmixer (Figure 4a ). The mesh was simplified and smoothed where needed. The aortic root was extruded at both the inflow and outflow, by appending a 30 mm cylinder through the root (Figure 4b ). The three main coronary arteries were also extruded at the outlets. Pressure ports were appended to the aortic and the three main coronary arteries with 4 mm diameters acting as sites to place fluid pressure sensors for flow testing purposes (Figure 4c ). The Meshmixer "make solid" command was employed with an offset thickness of 2mm. The inner lumen was combined to the solid mesh to form a hollow 3D printable vasculature. 1, 6, 8 The inlets and outlets of the model were finally cut to allow for interior flow immersion (Figure 4d ). Vessel Outflow -
Mimic Capillary Bed
A support structure for the 3D printable anatomy was then designed in SolidWorks, which allowed for support at each vessel outlet as well as at the aortic root. The support structure was imported into Meshmixer and oriented around the vasculature. The Boolean Difference operation was performed between the support structure and the anatomy. The support and the vasculature was then combined to create a single structure (Figure 4e ). This completed design was then exported from Meshmixer as an STL file. An Object Polyjet 3D printer, Model260 V (Objet-Stratasys, Inc. Eden Prairie, MN) was used to print the model in TangoPlus (Figure 4f ). Figure 4 displays the workflow involved in converting the luminal anatomy STL file to the final 3D-printable model.
Benchtop Cardiovascular Flow Determination:
The 3D printed patient-specific cardiovascular models were connected to a programmable pulsatile pump, Compu-Flow 1000 (Shelley Medical London, Ontario Canada), and pressure was measured both proximal and distal to the stenosis using pressure transducers. A water/ glycerol solution was formulated to simulate the viscosity of the blood and aids in physiologically accurate resistance across the vessels. The flow rate was maintained within a physiologically accurate range and the distal resistance also remained constant with the incorporation of mechanical clamps simulating capillary bed resistance. The pressure data was collected using an NI Max ELVIS breadboard and LabVIEW program, enabling calculation of the Benchtop FFR from the recorded pressure drops under pulsatile flow. Figure 5 and Figure 6 display the benchtop system setup with the incorporation of the 3D printed model, mechanical clamps, damper and pressure sensors. 
Results
Twelve patients were included in this study and successfully underwent all three FFR techniques: Angio-FFR, CT-FFR, and Benchtop FFR. Table 1 For purposes of the below analysis, Angio-FFR is considered the reference standard of the FFR value, and compared against the Benchtop FFR and CT-FFR values. We are then able to validate the CT-FFR measurements with the Benchtop-FFR results. In Figure 7 angiography results are compared for Patients #4 (Figure 7a ) and #10 (Figure 7b) , both of which contained stenosis present in the left anterior descending (LAD) artery.
Patient
CCTA data was used to determine CT-FFR (Canon Medical Systems and Vital Images). PfF-C'1{32 loniSo I.at' for mil,/ of Rid An STL file is exported from Vital Images after both automatic and manual lumen segmentation. The vascular geometry is transformed into a 3D mesh with hollowed out vessel lumens and appended pressure sensors ports, compatible for 3D printing. Figure 9 displays the aortic root and three main coronary arteries within Autodesk Meshmixer with a support structure created in Solidworks. 
Discussion
In this study we demonstrate the preliminary results of using the patient specific 3D printed coronary models to simulate blood flow conditions similar to those observed in humans. High printing resolution, advance printing polymers, precise segmentation software (Vitrea, Vital Images) and intuitive mesh manipulation software (Autodesk Meshmixer) can allow researchers to build patient specific vascular models with high anatomical and mechanical accuracy. These precise patient specific vascular phantoms can be further use to perform reliable blood flow simulation experiments and allow for measurement of physiological parameters associated with vascular disease. Previous compliance testing data by Sommer et. al. demonstrated that the material properties of our 3D printed models to accurately simulate human coronary vasculature. 2 Cardiac blood flow analysis has further advanced our abilities to program pulsatile waveforms and reported flow rates into our pulsatile pump. Therefore, we have built a non-invasive tool to further advance the analysis of coronary lesions with regards to hemodynamic significance, information which currently is mainly retrieved through invasive Angio-FFR determination.
The pressure readings we have obtained through our benchtop models prove to be strongly correlated to Angio-FFR with a Pearson correlation of 0.871. The Pearson correlation between Benchtop-FFR and CT-FFR is 0.877 which indicates that our benchtop models can be used to validate CT-FFR software, specifically an algorithm which incorporates hemodynamic significance. A Pearson correlation of 0.927 between CT-FFR and Angio-FFR proves the accuracy of the CT-FFR software in comparison to the "gold standard" Angio-FFR.
With an R-value of 0.8838 between all three FFR determination methods (Angio-FFR, Benchtop FFR, CT-FFR), it can be concluded that the data is tightly fitted to the line of regression, that being a linear model. This test of linearity concludes a depiction of FFR readings that have very little deviation from one another, confirming that Benchtop FFR is accurate when being compared to Angio-FFR as well as CT-FFR having a strong correlation to both Benchtop FFR and Angio-FFR.
The average of the percent difference of Angio-FFR/Benchtop FFR, Benchtop FFR/CT-FFR, and Angio-FFR/CT-FFR is 5.97, 7.89, and 6.47, respectively. With average percent differences of <8%, the accuracy of our pressure data proves that anatomic and physiological accuracy are maintained in our benchtop models and the CT-FFR software. Benchtop FFR is highly accurate in comparison to the "gold standard" Angio-FFR and can therefore be used as a tool to validate CT-FFR software and any other image-based diagnostic software.
3D printed patient specific cardiovascular models can therefore be used to simulate in vivo hyperemic blood flow conditions and thus used to validate CT-FFR diagnostic software giving the medical community an estimation of atherosclerotic lesion severity pre-ICA.
Conclusions
We presented a straightforward workflow for data acquisition and creation of physiologically and geometrically accurate 3D printed cardiovascular coronary models that can be used to perform physiologically accurate blood flow simulations at hyperemic in vivo conditions. These models can be used to optimize and validate CT-FFR software that provides an estimation of atherosclerotic lesion severity under physiologically accurate flow conditions. 3D printed benchtop models are a tool which can be used pre-ICA to both reduce the cost and the risks during invasive procedures.
